UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062732
Receipt number R000071828
Scientific Title intervention study on the effect of transcutaneous electrical nerve stimulation on acute pain on the second day after total knee arthroplasty
Date of disclosure of the study information 2026/08/29
Last modified on 2026/08/29 08:51:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

intervention study on the effect of transcutaneous electrical nerve stimulation on acute pain on the second day after total knee arthroplasty

Acronym

intervention study on the effect of transcutaneous electrical nerve stimulation on acute pain on the second day after total knee arthroplasty

Scientific Title

intervention study on the effect of transcutaneous electrical nerve stimulation on acute pain on the second day after total knee arthroplasty

Scientific Title:Acronym

intervention study on the effect of transcutaneous electrical nerve stimulation on acute pain on the second day after total knee arthroplasty

Region

Japan


Condition

Condition

Knee osteoarthritis

Classification by specialty

Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the factors associated with the efficacy of transcutaneous electrical nerve stimulation (TENS) for acute postoperative pain following total knee arthroplasty (TKA).

Basic objectives2

Others

Basic objectives -Others

Although transcutaneous electrical nerve stimulation (TENS) is widely utilized as a non-pharmacological intervention for acute postoperative pain management following total knee arthroplasty (TKA), individual pain relief responses vary substantially. The objective of this study is to investigate the patient-related characteristics and factors (e.g., preoperative pain characteristics, psychosocial factors, and quantitative sensory testing profiles) associated with the analgesic efficacy of TENS, thereby identifying potential predictors of responsiveness to TENS in this patient population.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in visual analog scale (VAS) score before and after transcutaneous electrical nerve stimulation (TENS)

Key secondary outcomes

PCS,TSK,PHQ-2,GAD-2,CSI-9,QST


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Standardized TENS intervention using a portable electrical stimulator (ITO ESPURGE, Ito Co., Ltd.). Four surface electrodes are placed 5 cm superior and inferior to the surgical incision on both medial and lateral sides. Stimulation parameters: frequency 2 100 Hz, pulse width 100 microseconds, and intensity adjusted to the maximum tolerable sensory threshold without muscle contraction or pain. Each session lasts 40 minutes and is administered during daily physical therapy sessions from postoperative day 2 to day 14. Standard postoperative physical therapy (e.g., range of motion exercises, muscle strengthening, and gait training) is provided concurrently as usual care.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with knee osteoarthritis undergoing primary total knee arthroplasty (TKA) Age 18 years or older Ability to read and write Capable of proper communication No prior history of TENS or opioid use preoperatively No history of chronic pain disorders, or alcohol/substance abuse Absence of an implanted cardiac pacemaker No neurological disorders Approved for TENS application by the attending surgeon/physician Written informed consent obtained from the patient

Key exclusion criteria

Presence of postoperative complications (e.g., surgical site infection, deep vein thrombosis) Hemodynamic instability Patients undergoing revision or secondary surgery postoperatively Patients who have prior knowledge or specific expectation of TENS analgesic efficacy

Target sample size

100


Research contact person

Name of lead principal investigator

1st name KAZUKI
Middle name
Last name TANAKA

Organization

Shimane University Hospital

Division name

Department of Rehabilitation

Zip code

6938501

Address

89-1 Enya-cho, Izumo, Shimane 693-8501, Japan

TEL

0853202457

Email

tanaka31@med.shimane-u.ac.jp


Public contact

Name of contact person

1st name KAZUKI
Middle name
Last name TANAKA

Organization

Shimane University Hospital

Division name

Department of Rehabilitation

Zip code

69388501

Address

89-1 Enya-cho, Izumo, Shimane 693-8501, Japan

TEL

0853202457

Homepage URL


Email

tanaka31@med.shimane-u.ac.jp


Sponsor or person

Institute

Shimane University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Research Ethics Committee, Faculty of Medicine, Shimane University

Address

89-1 Enya-cho, Izumo, Shimane 693-8501, Japan

Tel

0853-20-2515

Email

kenkyu@med.shimane-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 08 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 09 Month 08 Day

Date of IRB

2025 Year 12 Month 16 Day

Anticipated trial start date

2026 Year 01 Month 14 Day

Last follow-up date

2028 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 08 Month 29 Day

Last modified on

2026 Year 08 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071828